Ignyta (RXDX) Enters Licensing Agreement with Lilly (LLY) Covering Taladegib
Tweet Send to a Friend
Ignyta (NASDAQ: RXDX) announced the exclusive license of worldwide rights relating to Eli Lilly and Company’s (NYSE: LLY) taladegib oncology ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
